Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources.
暂无分享,去创建一个
[1] R. Hausinger,et al. Microbial ureases: significance, regulation, and molecular characterization. , 1989, Microbiological reviews.
[2] H. Mobley,et al. Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes , 1988, Journal of bacteriology.
[3] J. Tenney,et al. MR/K hemagglutination of Providencia stuartii correlates with adherence to catheters and with persistence in catheter-associated bacteriuria. , 1988, The Journal of infectious diseases.
[4] C. Hughes,et al. Production and properties of haemolysins from clinical isolates of the Proteeae. , 1988, Journal of medical microbiology.
[5] H. Mobley,et al. Urease-positive bacteriuria and obstruction of long-term urinary catheters , 1987, Journal of clinical microbiology.
[6] R. Welch. Identification of two different hemolysin determinants in uropathogenic Proteus isolates , 1987, Infection and immunity.
[7] M. Kerr,et al. Proteus mirabilis strains of diverse type have IgA protease activity. , 1987, Journal of medical microbiology.
[8] H. Mobley,et al. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection , 1987, Infection and immunity.
[9] V. Koronakis,et al. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli , 1987, Journal of Bacteriology.
[10] R. Cook,et al. Identification and characterization of a uroepithelial cell adhesin from a uropathogenic isolate of Proteus mirabilis , 1986, Infection and Immunity.
[11] H. Mobley,et al. Cloning of urease gene sequences from Providencia stuartii , 1986, Infection and immunity.
[12] C. Bauer,et al. The combination of pivampicillin and pivmecillinam versus pivampicillin alone in the treatment of acute pyelonephritis. , 1986, Scandinavian journal of infectious diseases.
[13] T. File,et al. Timentin versus piperacillin in the therapy of serious urinary tract infections. , 1985, The American journal of medicine.
[14] S Falkow,et al. Gal-Gal binding and hemolysin phenotypes and genotypes associated with uropathogenic Escherichia coli. , 1985, The New England journal of medicine.
[15] R. Adegbola,et al. Antigenic relationships among type-3 fimbriae of Enterobacteriaceae revealed by immunoelectronmicroscopy. , 1985, Journal of medical microbiology.
[16] R. Gleckman,et al. Therapy of symptomatic pyelonephritis in women. , 1985, The Journal of urology.
[17] U. Setia,et al. Bacteremia in a long-term care facility. Spectrum and mortality. , 1984, Archives of internal medicine.
[18] D. MacLaren,et al. Vero cell invasiveness of Proteus mirabilis , 1984, Infection and immunity.
[19] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[20] R. Adegbola,et al. The adhesins and fimbriae of Proteus mirabilis strains associated with high and low affinity for the urinary tract. , 1983, Journal of medical microbiology.
[21] A. Feinberg,et al. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.
[22] B. Jacobsson,et al. Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis. , 1983, The New England journal of medicine.
[23] W. Anthony,et al. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. , 1982, The Journal of infectious diseases.
[24] R. Adegbola,et al. Haemagglutinins and fimbriae of Morganella, Proteus and Providencia. , 1982, Journal of medical microbiology.
[25] R. Gleckman,et al. Symptomatic Pyelonephritis in Elderly Men , 1982, Journal of the American Geriatrics Society.
[26] L. Gentry,et al. Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis. , 1980, Scandinavian Journal of Infectious Diseases. Supplementum.
[27] J. Hamilton-miller,et al. Rapid screening for urease inhibitors. , 1979, Investigative urology.
[28] I. Ofek,et al. Influence of pili on the virulence of Proteus mirabilis in experimental hematogenous pyelonephritis. , 1978, The Journal of infectious diseases.
[29] T. Stamey,et al. Studies of introital colonization in women with recurrent urinary infections. X. Adhesive properties of Escherichia coli and Proteus mirabilis: lack of correlation with urinary pathogenicity. , 1978, The Journal of urology.
[30] F. Silverblatt. HOST-PARASITE INTERACTION IN THE RAT RENAL PELVIS , 1974, The Journal of experimental medicine.
[31] Pazin Gj,et al. Immobilizing antibodies in urine. II. Prevention of ascending spread of Proteus mirabilis. , 1974 .
[32] P. Gower,et al. The site of infection in 133 patients with bacteriuria. , 1973, Clinical nephrology.
[33] D. MacLaren,et al. The significance of urease in proteus pyelonephritis: a bacteriological study. , 1968, The Journal of pathology and bacteriology.
[34] K. Fairley,et al. Simple test to determine the site of urinary-tract infection. , 1967, Lancet.
[35] J. Marmur. A procedure for the isolation of deoxyribonucleic acid from micro-organisms , 1961 .
[36] A. Braude,et al. ROLE OF BACTERIAL UREASE IN EXPERIMENTAL PYELONEPHRITIS , 1960, Journal of bacteriology.